Alfasigma — Home

Potential partnering database.

Biotech event calendar and key milestones.

Highlight the main evaluation criteria of potential biotech partnering opportunities (preclinical/early clinical)

Identify up to 20 partnering candidates, score PPI, and summarize funding, stage, and fit.

Analyze a company or asset deck for fit to Alfasigma, covering snapshot, unmet need, modality, criteria scores, and recommendation.

Competitive landscape of a particular modality, field or indication.

Technical analysis of a new technology or landscape in a particular indication.

Identify leading KOLs with scoring, snapshots, visuals, and engagement recommendations.

Executive summary of funding and partnering trends for a modality/indication with implications and recent deals.

Full investor memo covering USP, science, plan, regulatory, CMC, IP, market, team, finances, and key questions.

Sell-side memo with market, epidemiology, pricing, rNPV model, comps, sensitivities, and appendix.

FTO analysis with patent tables, blocking claims, licensing, litigation, risk matrix, and mitigations.

CEO dossier on scientific record, leadership, exits, investors, company performance, and risks.

Shortlist and benchmark of 20+ CEO candidates with bios, scoring, and outreach plan.

Scout 20+ researchers for a scientific challenge with profiles, scorecard, and partnership guidance.

Excel landscape of pre-approval companies with selection criteria, universe table, shortlist, scoring matrix, and recommendations.